Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Vaccination with the pneumococcal vaccine GSK 1024850A or Prevenar™ at approximately 4 years of age in children primed with 3 doses of GSK 1024850A vaccine or Prevenar™ and boosted with 23-valent pneumococcal plain polysaccharide vaccine
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
112807
NCT00907777
Infections, Streptococcal
Phase 3
 
This is a follow up study to 105554 and 106623.
March 2015

Powered by ideaPoint, Inc.